Navigation Links
Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Date:9/11/2007

ficer of Anadys. "In chronic viral diseases, achieving blood levels in preclinical studies that are many-fold above concentrations needed for viral suppression is generally recognized as a predictor of potential clinical utility."

In June, Anadys announced the nomination of ANA598 as a clinical development candidate. ANA598 was selected from the Company's internal NS5B discovery efforts based on an optimized balance of preclinical properties and was the result of the Company's structure-based drug design capabilities. ANA598 is undergoing IND enabling activities and an IND submission is targeted for the first half of 2008.

"After completing the necessary IND enabling studies, we look forward to exploring the potential clinical utility of ANA598 in patients with HCV," said James Freddo, MD, Anadys' Chief Medical Officer. "Based on the combined potency, pharmacokinetic and preliminary toxicologic properties of ANA598, we believe that this is an exciting new direct antiviral to investigate for the treatment of patients with hepatitis C virus infection."

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company committed to advancing patient care by developing and commercializing novel small molecule medicines for the treatment of hepatitis C virus (HCV) infection and cancer. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of HCV and ANA773, an oral TLR7 agonist prodrug for cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to the expected timing and planned development activities for ANA598, the prediction that ANA598 has a low likelihood of producing clinical drug-drug interactions, the use of doses in preclinical studies that are designed to be predictive of human doses, the belief that achievin
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
2. Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2008)... 2008 Faces of Influenza survey underscores that m...uenza; Mother and Gold Medalist Kristi Yamaguchi j...RNewswire/ -- While 78 percent of mothers in the U...tially life-threatening disease that can strike an...ll get vaccinated this season, according to a new ...
(Date:11/13/2008)...itional Supplements Prior to Surgery, ARLINGTON H...dentifying,malnutrition before surgery in massive ...significantly decrease surgical complications, acc...ost patient energy levels,according to a study in...Surgery(R), the official medical journal of the Am...
(Date:11/12/2008)...h James D. Watson, Marilyn & James Simons and,Sher..., Md., Nov. 12 J. Craig...aig Venter Institute (JCVI), was,awarded the Doubl...CSHL) on,November 6th at a gala event in New York ... along with Dr. James D.,Watson for making each of...
(Date:11/12/2008)... Study and New Data Suggesting Need for Improved ...l Meeting -, EXTON, Pa., Nov. 12 /PRNewswire-Firs... today announced the presentation of data from its...tudy Cinryze(TM) C1 inhibitor,therapy successfully...(HAE),attacks seen in the study through the date o...
Breaking Medicine Technology:Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 1Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 2Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 3Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 4Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 55th Annual World Health Care Congress Kicks off April 21 With Obama Clinton McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 17263 15th Annual World Health Care Congress Kicks off April 21 With Obama Clinton McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 17263 2 C O R R E C T I O N Mobidiag Ltd 4718 1 C O R R E C T I O N Mobidiag Ltd 4718 2Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 1Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 2Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 3
(Date:11/21/2008)... Calif., Nov. 21 Album Creative St...launches a new program offering big brand marketin...the large, expensive ad agency process and service...ry hands-on approach," says Matt Parker, Creative ...ines experience and proven brand-building techniqu...
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...ugs (NSAIDs) are known to enable manifold benefits...ead carefully, evaluating potential risks before s...rding to a diverse expert panel.// Gastrointestin...of NSAID use that could mean complications in both...
...ineered mice has revealed that the dreaded white b...or transplants may also help prevent such damage//...chers have long known that when blood flow is cut ...kidneys or other organs, immune system cells calle...
...immune systems of fish and mammals in the form of ...of the immune system //has been discovered by rese... of Veterinary Medicine. Their studies link the e...in mammals, where B cells produce antibodies to fi...
...ter has become the first hospital in the region to...h doctors believe will change the standard of care...R/Cath Lab, the state-of-the-art operating suite h... devices necessary to perform open-heart surgeries...
Other Medicine News:Health News:Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications. 2Health News:Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications. 3Health News:Study Reveals Effects of WBCs on Transplanted Kidney 2Health News:Study Reveals Effects of WBCs on Transplanted Kidney 3Health News:Link between Fish and Mammal Immune Systems Revealed by Killer B cells 2Health News:Link between Fish and Mammal Immune Systems Revealed by Killer B cells 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 2Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: